In this large, consecutive series of unselected patients with breast cancer, all of the patients and physicians were not aware of the BRCA1/2 variant status when they selected BCT or mastectomy, largely depending on the tumor characteristics per se and the preferences of patients and physicians. The gene discussed is BRCA1; the disease is breast carcinoma.